Emerging Markets Survey Shows Limited Premium For International Drug Brands-Credit Suisse
This article was originally published in PharmAsia News
Executive Summary
A recent Credit Suisse report showed acceptability for global brands widely varied in emerging markets. While consumers did not show a great degree of trust for local pharmaceutical brands, the premium they are willing to pay for an international brand is also limited.